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Phenylbutazone	 2-20	mg/kg	orally	q.	8-12	hours	 Management	of	mild	to	moderate	pain	and	 COX-1	inhibitor	
inflammation	in	osteoarthritic	conditions.		Not	for	peri-operative	use.	Robenacoxib	 2	mg/kg	s.c.	once	daily	for	a	maximum	of	2	doses;		1–2	mg/kg	orally,	once	daily	(in	cats	for	up	to	6	days).		
Alleviation	of	inflammation	and	pain	in	both	acute	and	chronic	musculoskeletal	disorders,	and	the	reduction	of	postoperative	pain	and	inflammation	following	orthopaedic	and	soft	tissue	surgery	in	dogs.	Treatment	of	acute	pain	and	inflammation	in	cats.		
COX-2	selective	
Tolfenamic	acid	 Dogs	-	4	mg/kg	i.m.,	s.c.,	may	be	repeated	once	after	24h;	4	mg/kg	orally	for	3	days.		Oral	dosing	can	be	repeated	every	7	days	in	dogs		Cats	-	4	mg/kg	s.c.,	may	be	repeated	once	after	24h;	4	mg/kg	orally.	for	3	days.			
Alleviation	of	inflammation	and	pain	in	dogs	and	cats.	Also	used	in	the	management	of	chronic	locomotor	disease	in	dogs			
COX	inhibition,	direct	action	of	antagonism	on	PG	receptors	
COX	–	cyclo-oxygenase;	LOX	–	lipoxygenase;	OA	–	osteoarthritis;	PG	-	prostaglandin				 	
		Figure	1	–	Obesity	is	a	major	factor	in	osteoarthritis	and	weight	loss	remains	one	of	the	best	treatment	strategies	for	these	dogs		Figure	2	(a	and	b)	–	Passive	range	of	motion	exercises	such	as	joint	flexion	and	extension	can	easily	be	performed	at	home			Figure	3	(a	and	b)	-	Lateral	radiographs	of	the	tarsus	of	a	6-year-old,	Labrador	Retriever	with	a	chronic	calcaneal	tendon	injury	and	degenerative	joint	disease.	Pantarsal	arthrodesis	was	performed	to	stabilise	the	joint	and	manage	the	discomfort	associated	with	the	condition		Figure	4	(a	and	b)	-	Severe	hip	osteoarthritis	in	a	6-year-old,	German	Shepherd	Dog.	Femoral	head	and	neck	ostectomy	was	performed	to	relieve	clinical	signs	and	improve	limb	function	on	the	right.	The	dog	regained	good	limb	function	and	has	not	yet	required	further	surgery	on	the	contralateral	limb		Figure	5	(a	and	b)	-	Degenerative	change	in	the	hips	of	a	16-month-old	Labradoodle.	Total	hip	arthroplasty	was	performed	to	improve	this	dogs’	quality	of	life	due	to	severe	lameness	and	discomfort	during	hip	manipulation.	Significant	improvement	was	seen	after	surgery				 	
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